<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-08-20T15:41:16Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/131224" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/131224</identifier><datestamp>2026-01-29T01:16:30Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Hemodiafiltration with endogenous reinfusion improved microinflammation and endothelial damage compared with online-hemodiafiltration: a hypothesis generating study</dc:title>
   <dc:creator>Esquivias Motta, Elvira</dc:creator>
   <dc:creator>Martín Malo, Alejandro</dc:creator>
   <dc:creator>Buendía, Paula</dc:creator>
   <dc:creator>Álvarez Lara, María A.</dc:creator>
   <dc:creator>Soriano, Sagrario</dc:creator>
   <dc:creator>Crespo, Rodolfo</dc:creator>
   <dc:creator>Carracedo Añón, Julia María</dc:creator>
   <dc:creator>Ramírez, Rafael</dc:creator>
   <dc:creator>Aljama, Pedro</dc:creator>
   <dc:subject>616.61</dc:subject>
   <dc:subject>616.12</dc:subject>
   <dc:subject>612</dc:subject>
   <dc:subject>Adsorption</dc:subject>
   <dc:subject>Endothelial dysfunction</dc:subject>
   <dc:subject>Hemodiafiltration with endogenous reinfusion</dc:subject>
   <dc:subject>Inflammation</dc:subject>
   <dc:subject>Online-hemodiafiltration</dc:subject>
   <dc:subject>Uremic toxins</dc:subject>
   <dc:subject>Nefrología y urología</dc:subject>
   <dc:subject>Sistema cardiovascular</dc:subject>
   <dc:subject>Fisiología</dc:subject>
   <dc:subject>3205.06 Nefrología</dc:subject>
   <dc:subject>2411.03 Fisiología Cardiovascular</dc:subject>
   <dc:subject>3207.04 Patología Cardiovascular</dc:subject>
   <dc:description>Acknowledgments:
This work was supported by Plan Nacional Proyectos de Investigación en Salud of Instituto de Salud Carlos III (ISCIII) Fondos Feder Grants (PI10/00960, PI11/01536, PI12/01489, and PI14/00806); Junta de Andalucía Grants (P010-CTS-6337, P11-CTS-7352); Fundación Nefrológica and an unrestricted grant from Bellco S.r.l., Mirandola, Italy. Julia Carracedo was supported by a contract from Fundación de Investigaciones Biomédicas de Córdoba (Servicio Andaluz de Salud, Programa Nicolás Monardes).</dc:description>
   <dc:description>Hemodiafiltration with endogenous reinfusion (HFR) after ultrafiltrate passage through a resin cartridge combines adsorption, convection, and diffusion. Our prospective single-center crossover study compared HFR and online-hemodiafiltration (OLHDF) effects on two uremic toxins and 13 inflammatory, endothelial status, or oxidative stress markers.
After an 8-week run-in period of high-flux hemodialysis, 17 eligible stable dialysis patients (median age 65 years, 10 male) without overt clinical inflammation were scheduled for four 8-week periods in the sequence: HFR/OLHDF/HFR/OLHDF.
Relative to OLHDF, HFR was associated with greater indoxyl sulfate removal and lesser abnormalities in all other study variables, namely circulating interleukin-6, tumor necrosis factor-alpha, proportions of activated proinflammatory (CD14+CD16+, CD14++CD16+) monocytes, endothelial progenitor cells, apoptotic endothelial microparticles, vascular endothelial growth factor, vascular cellular adhesion molecule, angiopoietins 2 and 1, annexin V, and superoxide dismutase. Differences were significant (P &lt; 0.05) in median values of 13/15 variables. Study period comparisons were generally consistent with dialysis technique comparisons, as were data from the subgroup completing all study periods (n = 9).
Our investigation provides hypothesis-generating results suggesting that compared with OLHDF, HFR improves protein-bound toxin removal, inflammatory and endothelial status, and oxidative stress.</dc:description>
   <dc:description>European Commission</dc:description>
   <dc:description>Instituto de Salud Carlos III (España)</dc:description>
   <dc:description>Junta de Andalucía</dc:description>
   <dc:description>Fundación Nefrológica de Córdoba</dc:description>
   <dc:description>Fundación de Investigaciones Biomédicas de Córdoba</dc:description>
   <dc:description>Bellco</dc:description>
   <dc:description>Depto. de Genética, Fisiología y Microbiología</dc:description>
   <dc:description>Fac. de Ciencias Biológicas</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2026-01-28T18:54:35Z</dc:date>
   <dc:date>2026-01-28T18:54:35Z</dc:date>
   <dc:date>2016-05</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/131224</dc:identifier>
   <dc:identifier>0160-564X</dc:identifier>
   <dc:identifier>10.1111/aor.12704</dc:identifier>
   <dc:identifier>1525-1594</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>info:eu-repo/grantAgreement/MICINN//PI11%2F01536/ES/Senescencia de células endoteliales y generación de microparticulas. Un mecanismo comun en la etiopatogenia de la arteriosclerosis del anciano y el enfermo con insuficiencia renal crónica/</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/MINECO//PI12%2F01489/ES/Inflamación y enfermedad vascular calcificante en la uremia: Identificación de nuevas dianas diagnósticas y terapéuticas/</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/MINECO//PI14%2F00806/ES/Papel de microRNAs vehiculados por microparticulas de células senescentes en la enfermedad vascular asociada a la enfermedad renal crónica por nefropatía diabética/</dc:relation>
   <dc:relation>Esquivias-Motta E, Martín-Malo A, Buendia P, Álvarez-Lara MA, Soriano S, Crespo R, Carracedo J, Ramírez R, Aljama P. Hemodiafiltration With Endogenous Reinfusion Improved Microinflammation and Endothelial Damage Compared With Online-Hemodiafiltration: A Hypothesis Generating Study: Thoughts and Progress. Artificial Organs 2017;41:88–98. https://doi.org/10.1111/aor.12704.</dc:relation>
   <dc:rights>restricted access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Wiley</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>